QTTB FY 2022 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M-80.4% YoY

Gross Profit

$7M100.0% margin

Operating Income

-$39M-589.8% margin

Net Income

-$43M-643.6% margin

EPS (Diluted)

$-13.42

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$62M

Total Liabilities

$192M

Stockholders' Equity

-$131M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$34M	-80.4%
Gross Profit	$7M	$24M	-72.8%
Operating Income	-$39M	-$96M	+59.1%
Net Income	-$43M	-$96M	+55.3%